Skip to content
Dr. Grey AI

Supplement

Andrographis

Andrographis is a bitter herb from South and Southeast Asia whose compounds appear to calm inflammation and stimulate immune activity. Most people look at it for acute respiratory infections such as colds, and a large meta-analysis found symptoms improved versus placebo, usual care and other herbal therapies, with cough and sore throat easing too. Those cough and sore throat trials were fairly small, though, and the evidence for flu is limited.

Best evidence
Grade A
Conditions studied
3
Outcomes
5
Graded outcomes
3200

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

3 conditions

Upper Respiratory Infection

Upper Respiratory Infection: outcomes studied for Andrographis
GradeOutcomeEffectSizeStudiesPeopleStudies list
URTI Symptoms

Significantly improves overall ARTI symptoms vs placebo, usual care, and other herbal therapies (meta-analysis)

Improves (the measure goes down)Moderate effect7,175 people
Cough

Significant improvement in cough (SMD -0.39) compared to placebo

Improves (the measure goes down)Moderate effect596 people
Sore Throat

Large effect on sore throat symptoms (SMD -1.13) vs placebo

Changes; see studiesLarge effect314 people
Rheumatoid Arthritis (RA): outcomes studied for Andrographis
GradeOutcomeEffectSizeStudiesPeopleStudies list
RA Markers

Reduced rheumatoid factor, IgA, and C4 levels

Improves (the measure goes down)Moderate effect60 people
Immune Health: outcomes studied for Andrographis
GradeOutcomeEffectSizeStudiesPeopleStudies list
CD4+ Count

Significant increase in CD4+ counts; enhanced NK cell cytotoxicity (45%)

Improves (the measure goes up)Moderate effect30 people

Key findings

  • URTI SymptomsImproves (the measure goes down)
  • CoughImproves (the measure goes down)
  • Sore ThroatChanges; see studies

Shop the evidence-backed picks

Third-party tested Andrographis products, in the forms the graded studies used where we can match them.

  • Grade A

Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure

Studies cited

7 studies from PubMed

  1. Safety of Andrographis paniculata: A systematic review and meta-analysisPharmacoepidemiol Drug Saf, 2021 · PMID 33372366
  2. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolideCrit Rev Food Sci Nutr, 2019 · PMID 30040451
  3. Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysisPLoS One, 2017 · PMID 28783743
  4. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of actionInt Immunopharmacol, 2017 · PMID 28377280
  5. Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent AndrographolideEvid Based Complement Alternat Med, 2010 · PMID 23634174
  6. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trialsJ Clin Pharm Ther, 2004 · PMID 14748896
  7. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacyPlanta Med, 2004 · PMID 15095142